Tempus AI, Inc. (FRA:F3M)

Market Cap	8.96B +67.6%
Revenue (ttm)	942.01M +72.6%
Net Income	-173.76M
EPS	-1.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	181
Average Volume	597
Open	52.00
Previous Close	53.00
Day's Range	50.50 - 52.00
52-Week Range	47.20 - 90.00
Beta	n/a
RSI	37.63
Earnings Date	Feb 26, 2026

About Tempus AI

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharma...

• Industry: Medical Laboratories
• Founded: 2015
• Employees: 2,400
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: F3M

Financial Performance

In 2024, Tempus AI's revenue was $693.40 million, an increase of 30.38% compared to the previous year's $531.82 million. Losses were -$746.33 million, 180.6% more than in 2023.

Financial numbers in USD